• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION Back to Search Results
Model Number ESS305
Device Problems Migration or Expulsion of Device (1395); Device Or Device Fragments Location Unknown (2590)
Patient Problem No Information (3190)
Event Type  Injury  
Event Description
This is a spontaneous case report received from a nurse in united states on (b)(4) 2014 which refers to a female patient of unspecified age who had essure (fallopian tube occlusion insert) inserted.Reporter stated that a patient's left coil was removed but the right coil could not be found by healthcare professional.Stated that it could not be detected via ultrasound but was detected via ct scan.Refused interview and follow up.Ptc investigation result was received on (b)(4) 2014.This adverse event report is related to a product technical complaint (ptc).The bayer reference number for the ptc report is: (b)(4).Final assessment: since no product was returned to us for investigation, we were unable to perform an investigation of the actual device involved in this complaint.Typically, we would inspect the micro-insert to confirm that all parts are accounted for and inspect the device to look for any manufacturing deficiencies.Since we have no valid lot number for this case, we were unable to conduct a review of the manufacturing batch record.We are unable to confirm any quality defect or device malfunction at this time.Medical assessment: this ptc was initiated due to a request for confirmation of quality.The reported adverse events are known, possible, undesirable events and not indicative of a quality deficit per se.No batch number was reported.Without this information no batch signal cluster review in the (b)(4) database for a more detailed statistical medical evaluation is possible.No complaint sample was provided for further technical investigation.The technical assessment concluded "unconfirmed quality defect".In summary, there is no reason to suspect a causal relationship to a potential quality deficit.Company causality comment: this medically confirmed, spontaneous case report refers to a female patient who had essure (fallopian tube occlusion insert) inserted and had left coil removed but the right coil could not be found, it could not be detected via ultrasound but was detected via ct scan.The reported event right coil could not be found, it could not be detected via ultrasound but was detected via ct scan was considered as suspicion of device migration.Both events were considered serious due to medical importance and listed for essure in the reference safety information.Sometimes migration through the fallopian tube is suspected, because the essure insert is found in the abdomen and no apparent perforation can be identified.In this case, it was unknown the exact location of right coil.It was not reported the reason why the left coil was removed.Also, the exact day of left coil removal and the type of surgery were unknown.Based on the information provided, a causal relationship between the reported events and suspect insert cannot be excluded.Although the reason for removal of left coil was not reported, this case was regarded as incident.According to product technical analysis, there is no reason to suspect a causal relationship to a potential quality deficit.The reporter refused interview.No further information will be requested.
 
Manufacturer Narrative
Data correction for us reporting: the code knh was replaced with hhs.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
INSERT, TUBAL OCCLUSION
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, CA 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, CA 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd.
p.o. box 915
whippany, NJ 07981-0915
MDR Report Key4226194
MDR Text Key4997628
Report Number2951250-2014-00471
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,health professional,oth
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 01/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/08/2014
Initial Date FDA Received11/05/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-